title: Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells.
abstract: Aberrant loss of oocytes following cancer treatments or genetic mutations leads to premature ovarian insufficiency (POI) associated with endocrine-related disorders in 1% of women. Therefore, understanding the mechanisms governing oocyte death is crucial for the preservation of female fertility. Here, we report the striking reproductive features of a novel mouse model of POI obtained through oocyte-specific inactivation (ocKO) of Omcg1/Zfp830 encoding a nuclear zinc finger protein involved in pre-mRNA processing. Genetic ablation of OMCG1 in early growing oocytes leads to reduced transcription, accumulation of DNA double-strand breaks and subsequent c-Abl/TAp63-dependent oocyte death, thus uncovering the key role of OMCG1 for oocyte genomic integrity. All adult Omcg1(ocKO) females displayed complete elimination of early growing oocytes and sterility. Unexpectedly, mutant females exhibited a normal onset of puberty and sexual receptivity. Detailed studies of Omcg1(ocKO) ovaries revealed that the ovarian somatic compartment underwent a dramatic structural and functional remodeling. This allowed the cooperation between oocyte-depleted follicles and interstitial tissue to produce estradiol. Moreover, despite early folliculogenesis arrest, mutant mice exhibited sexual cyclicity as shown by cyclical changes in estrogen secretion, vaginal epithelium cytology and genital tract weight. Collectively, our findings demonstrate the key role of Omcg1 for oocyte survival and highlight the contribution of p63 pathway in damaged oocyte elimination in adulthood. Moreover, our findings challenge the prevailing view that sexual cyclicity is tightly dependent upon the pace of folliculogenesis and luteal differentiation.
authors.affiliation: 1] Institut Pasteur, Unité de Génétique Fonctionnelle de la Souris, Département de Biologie du Développement et Cellules Souches, 25 rue du docteur Roux, Paris F-75015, France [2] CNRS URA 2578, Paris F-75015, France.
authors.forename: S
authors.initials: S
authors.lastname: Vandormael-Pournin
authors.affiliation: 1] INSERM U1133, Physiologie de l'Axe Gonadotrope, Paris F-75013, France [2] Université Paris Diderot, Sorbonne Paris Cité, Paris F-75013, France [3] CNRS, UMR 8251, Biologie Fonctionnelle et Adaptative, Paris F-75013, France.
authors.forename: C J
authors.initials: CJ
authors.lastname: Guigon
authors.affiliation: 1] INSERM U1133, Physiologie de l'Axe Gonadotrope, Paris F-75013, France [2] Université Paris Diderot, Sorbonne Paris Cité, Paris F-75013, France [3] CNRS, UMR 8251, Biologie Fonctionnelle et Adaptative, Paris F-75013, France.
authors.forename: M
authors.initials: M
authors.lastname: Ishaq
authors.affiliation: 1] INSERM U1133, Physiologie de l'Axe Gonadotrope, Paris F-75013, France [2] Université Paris Diderot, Sorbonne Paris Cité, Paris F-75013, France [3] CNRS, UMR 8251, Biologie Fonctionnelle et Adaptative, Paris F-75013, France.
authors.forename: N
authors.initials: N
authors.lastname: Coudouel
authors.affiliation: Institut Pasteur, Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Paris F-75015, France.
authors.forename: P
authors.initials: P
authors.lastname: Avé
authors.affiliation: Institut Pasteur, Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Paris F-75015, France.
authors.forename: M
authors.initials: M
authors.lastname: Huerre
authors.affiliation: 1] INSERM U1133, Physiologie de l'Axe Gonadotrope, Paris F-75013, France [2] Université Paris Diderot, Sorbonne Paris Cité, Paris F-75013, France [3] CNRS, UMR 8251, Biologie Fonctionnelle et Adaptative, Paris F-75013, France.
authors.forename: S
authors.initials: S
authors.lastname: Magre
authors.affiliation: 1] INSERM U1133, Physiologie de l'Axe Gonadotrope, Paris F-75013, France [2] Université Paris Diderot, Sorbonne Paris Cité, Paris F-75013, France [3] CNRS, UMR 8251, Biologie Fonctionnelle et Adaptative, Paris F-75013, France.
authors.forename: J
authors.initials: J
authors.lastname: Cohen-Tannoudji
authors.affiliation: 1] Institut Pasteur, Unité de Génétique Fonctionnelle de la Souris, Département de Biologie du Développement et Cellules Souches, 25 rue du docteur Roux, Paris F-75015, France [2] CNRS URA 2578, Paris F-75015, France.
authors.forename: M
authors.initials: M
authors.lastname: Cohen-Tannoudji
mesh_terms: D000818:Animals; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism*; D016923:Cell Death; D002470:Cell Survival; D004967:Estrogens / Q000378:metabolism; D005260:Female; D042822:Genomic Instability / Q000502:physiology*; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D009865:Oocytes / Q000166:cytology / Q000378:metabolism*; D010053:Ovary / Q000166:cytology / Q000378:metabolism*; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D016315:Proto-Oncogene Proteins c-abl / Q000235:genetics / Q000378:metabolism; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism*
chemical_list: D018797:Cell Cycle Proteins; D004967:Estrogens; D009687:Nuclear Proteins; C503327:OMCG1 protein, mouse; D010750:Phosphoproteins; D015534:Trans-Activators; C486419:Trp63 protein, mouse; D016315:Proto-Oncogene Proteins c-abl